2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione

Catalog No. :
ACQAOU734
CAS No. :
19667-37-9
Molecular Formula :
C11H10ClNO3
Molecular Weight :
239.66

IUPAC Name:2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione

2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$99.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione
IUPAC Name2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione
MDL No.MFCD00086198
Molecular FormulaC11H10ClNO3
Molecular Weight239.66
SMILESO=C(N1CC(O)CCl)C2=CC=CC=C2C1=O
InChI KeyKBRVYEPWGIQEOF-UHFFFAOYSA-N
Synonym2-(3-Chloro-2-hydroxypropyl)-2H-isoindole-1,3-dione;N-(3-Chloro-2-hydroxypropyl)phthalimide;Rivaroxaban Impurity 120;1H-Isoindole-1,3(2H)-dione, 2-(3-chloro-2-hydroxypropyl)-;2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione;SJM-SM-3-IM-4
CAS No.19667-37-9
PubChem CID262103

Safety Data

Pictogram
ToxicHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331-H341
Precautionary Statement(s)
P201-P202-P261-P264-P270-P271-P280-P302+P352-P304+P340-P308+P313-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQAOU734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACQAOU734 route product structure diagram
    ACQAOU73419667-37-9 In Stock
Inquiry

2. ACQAOU734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACQAOU734 route product structure diagram
    ACQAOU73419667-37-9 In Stock
Inquiry

Comments (0)